Clinigen To Test U.K. Investors' Appetite For A Pharma Company IPO
This article was originally published in The Pink Sheet Daily
Executive Summary
A U.K. supplier of drugs for clinical trials and fledgling specialty pharma company, Clinigen Group, has announced its intention to test U.K. investors' appetite for a pharmaceutical company IPO, with a listing and institutional fundraising on AIM, part of the London Stock Exchange.